AKAP13 regulates GLI1/ULK1 axis and drive tumor resistance to next-generation HER2-targeted therapies. Guo Q, Chen X, Wu L, Ren C, et al. Oncogene 2026;45:4132-4148.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guo Q, Chen X, Wu L, Ren C, et al. AKAP13 regulates GLI1/ULK1 axis and drive tumor resistance to next-generation HER2-targeted therapies. Oncogene 2026;45:4132-4148.
PMID: 42562949